Champions Oncology Inc Q2 2026 Earnings Call Transcript - Thomson StreetEvents

Champions Oncology Inc Q2 2026 Earnings Call Transcript

Champions Oncology Inc Q2 2026 Earnings Call Transcript - Thomson StreetEvents
Champions Oncology Inc Q2 2026 Earnings Call Transcript
Published Dec 15, 2025
6 pages (3262 words) — Published Dec 15, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of CSBR.OQ earnings conference call or presentation 15-Dec-25 9:30pm GMT

  
Brief Excerpt:

...Operator Greetings. Welcome to the Champions Oncology second quarter fiscal year 2026 earnings call. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, Rob Brainin, Chief Executive Officer. You may begin. Robert Brainin ...

  
Report Type:

Transcript

Source:
Company:
Champions Oncology Inc
Ticker
CSBR.OQ
Time
9:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Matthew Hewitt - Craig-Hallum Holdings LLC - Analyst : Good afternoon. Thanks for taking the questions. It sounds like cancellations have kind of gotten back to maybe historic levels. The funding environment is improving, so a lot of good things from an external standpoint. I'm just curious from an RFP perspective, the inbound call volume that you're receiving, have you seen an uptick there, and how quickly do you think you can translate that into, kind of getting back to that, recurring double-digit revenue growth?


Question: Matthew Hewitt - Craig-Hallum Holdings LLC - Analyst : That's great and regarding the the data platform, it's nice to see that you're making some investments there when you look at the the sales and marketing investments specifically, are those, new hires, are they specifically and exclusively targeting the data opportunity or are they also supporting, the PDX and some of the other services that you provide?


Question: Matthew Hewitt - Craig-Hallum Holdings LLC - Analyst : Got it. I guess lastly is on the margin side, specifically gross margins, a nice, pop here both sequentially and year-over-year. It sounds like this is kind of a way to think about the base business or the core business as you look out over the remainder of the year, what would, where could those go. So, you've obviously added a few people. I don't know if that's going to necessarily impact gross margins. It sounds like it's more OpEx, but can we expect to see further growth in gross margins, which in theory should be flowing through to the bottom line, or is there something that would cause those to kind of trick down a little bit here maybe in Q3 or Q4? Thank you.

Table Of Contents

Champions Oncology Inc Q1 2026 Earnings Call Transcript – 2025-09-15 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 15-Sep-25 8:30pm GMT

Champions Oncology Inc Q4 2025 Earnings Call Transcript – 2025-07-23 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 23-Jul-25 8:30pm GMT

Champions Oncology Inc Q3 2025 Earnings Call Transcript – 2025-03-11 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 11-Mar-25 8:30pm GMT

Champions Oncology Inc Q2 2025 Earnings Call Transcript – 2024-12-11 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 11-Dec-24 9:30pm GMT

Champions Oncology Inc Q1 2025 Earnings Call Transcript – 2024-09-11 – US$ 54.00 – Edited Transcript of CSBR.OQ earnings conference call or presentation 11-Sep-24 8:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Champions Oncology Inc Q2 2026 Earnings Call Transcript" Dec 15, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2026-Champions-Oncology-Inc-Earnings-Call-T16599365>
  
APA:
Thomson StreetEvents. (2025). Champions Oncology Inc Q2 2026 Earnings Call Transcript Dec 15, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2026-Champions-Oncology-Inc-Earnings-Call-T16599365>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.